Work

A phase II study of imatinib for advanced melanoma patients with KIT aberrations.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.8527

Authors: J. Guo, L. Si, Y. Kong, X. w. Xu, K. T. Flaherty, C. L. Corless, Y. Y. Zhu, L. Li, H. F. Li

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249200567

Cites:

Cited by: 12

Related to: 10